Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dentists | 1 | 2013 | 6 | 0.410 |
Why?
|
| Periodontitis | 2 | 2014 | 11 | 0.200 |
Why?
|
| Gingiva | 3 | 2012 | 8 | 0.200 |
Why?
|
| Tissue Scaffolds | 3 | 2013 | 88 | 0.190 |
Why?
|
| Mouth | 2 | 2014 | 31 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2010 | 160 | 0.150 |
Why?
|
| Breast Neoplasms | 5 | 2001 | 472 | 0.120 |
Why?
|
| Fusobacterium Infections | 1 | 2014 | 1 | 0.110 |
Why?
|
| Fusobacteria | 1 | 2014 | 1 | 0.110 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2014 | 6 | 0.110 |
Why?
|
| Dental Plaque | 1 | 2014 | 9 | 0.110 |
Why?
|
| Estrogen Antagonists | 3 | 1998 | 16 | 0.100 |
Why?
|
| Dentistry | 1 | 2013 | 3 | 0.100 |
Why?
|
| Schools, Dental | 1 | 2013 | 7 | 0.100 |
Why?
|
| Octoxynol | 1 | 2013 | 9 | 0.100 |
Why?
|
| Umbilical Cord | 1 | 2013 | 35 | 0.100 |
Why?
|
| Cell Movement | 3 | 2001 | 373 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2013 | 815 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 117 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 66 | 0.090 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 72 | 0.090 |
Why?
|
| Dental Prosthesis Design | 1 | 2011 | 5 | 0.090 |
Why?
|
| Tooth Socket | 1 | 2011 | 7 | 0.090 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 16 | 0.090 |
Why?
|
| Dental Prophylaxis | 1 | 1990 | 1 | 0.080 |
Why?
|
| Dental Scaling | 1 | 1990 | 1 | 0.080 |
Why?
|
| Plastics | 1 | 1990 | 6 | 0.080 |
Why?
|
| Stainless Steel | 1 | 1990 | 8 | 0.080 |
Why?
|
| Alloys | 1 | 1990 | 6 | 0.080 |
Why?
|
| Dental Implants | 1 | 1990 | 11 | 0.080 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 1 | 2010 | 3 | 0.080 |
Why?
|
| Titanium | 1 | 1990 | 37 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2010 | 25 | 0.080 |
Why?
|
| Oklahoma | 1 | 2013 | 1038 | 0.080 |
Why?
|
| Chitosan | 1 | 2007 | 34 | 0.070 |
Why?
|
| Brain Ischemia | 2 | 1998 | 87 | 0.070 |
Why?
|
| Activities of Daily Living | 2 | 1998 | 106 | 0.060 |
Why?
|
| Humans | 13 | 2014 | 28581 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 4 | 2001 | 190 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 534 | 0.050 |
Why?
|
| Brain | 2 | 1998 | 753 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2001 | 1 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 5 | 2001 | 314 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 46 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2012 | 391 | 0.040 |
Why?
|
| Tensile Strength | 2 | 2011 | 35 | 0.040 |
Why?
|
| Cell Line | 2 | 2013 | 698 | 0.040 |
Why?
|
| Biomechanical Phenomena | 2 | 2011 | 182 | 0.040 |
Why?
|
| Time Factors | 3 | 2010 | 1600 | 0.040 |
Why?
|
| Surface Properties | 2 | 2007 | 134 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 461 | 0.040 |
Why?
|
| Hemiplegia | 1 | 1998 | 3 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 11 | 0.040 |
Why?
|
| Gelatinases | 1 | 1997 | 14 | 0.030 |
Why?
|
| Paraplegia | 1 | 1997 | 3 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 65 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 75 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 193 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 133 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 328 | 0.030 |
Why?
|
| Tamoxifen | 3 | 1998 | 33 | 0.030 |
Why?
|
| Estradiol | 3 | 1998 | 175 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 515 | 0.020 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2014 | 259 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 82 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 69 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 667 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 207 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1009 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2013 | 152 | 0.020 |
Why?
|
| Middle Aged | 4 | 2012 | 7310 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2011 | 8 | 0.020 |
Why?
|
| Dental Stress Analysis | 1 | 2011 | 14 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 465 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 43 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 54 | 0.020 |
Why?
|
| Adult | 4 | 2012 | 7922 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1990 | 61 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1990 | 73 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 130 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 115 | 0.020 |
Why?
|
| Cell Count | 1 | 1990 | 86 | 0.020 |
Why?
|
| Sutures | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1990 | 139 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 238 | 0.020 |
Why?
|
| Animals | 3 | 2011 | 10580 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1990 | 278 | 0.020 |
Why?
|
| Female | 5 | 2012 | 15471 | 0.020 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2007 | 2 | 0.020 |
Why?
|
| Sodium Hydroxide | 1 | 2007 | 9 | 0.020 |
Why?
|
| Solutions | 1 | 2007 | 31 | 0.020 |
Why?
|
| Muramidase | 1 | 2007 | 13 | 0.020 |
Why?
|
| Porosity | 1 | 2007 | 38 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2007 | 16 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2007 | 29 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2007 | 26 | 0.020 |
Why?
|
| Male | 4 | 2012 | 13771 | 0.020 |
Why?
|
| Receptors, Estrogen | 2 | 1997 | 43 | 0.020 |
Why?
|
| Streptococcus mutans | 1 | 2007 | 39 | 0.020 |
Why?
|
| Mice | 2 | 2001 | 4732 | 0.020 |
Why?
|
| Ethanol | 1 | 2007 | 124 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 1998 | 782 | 0.010 |
Why?
|
| Aged | 3 | 1998 | 5525 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 164 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 1998 | 18 | 0.010 |
Why?
|
| Fibronectins | 1 | 1998 | 28 | 0.010 |
Why?
|
| Collagenases | 1 | 1997 | 5 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1997 | 13 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 1997 | 40 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1997 | 40 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1997 | 40 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1997 | 54 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 1997 | 25 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 169 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 253 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 123 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 524 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 681 | 0.010 |
Why?
|
| Adolescent | 1 | 1997 | 3165 | 0.000 |
Why?
|